SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-167885
Filing Date
2023-06-15
Accepted
2023-06-15 16:05:53
Documents
13
Period of Report
2023-06-15
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d520938d8k.htm   iXBRL 8-K 43176
2 EX-3.1 d520938dex31.htm EX-3.1 6493
  Complete submission text file 0001193125-23-167885.txt   179503

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sybx-20230615.xsd EX-101.SCH 2860
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE sybx-20230615_lab.xml EX-101.LAB 18740
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sybx-20230615_pre.xml EX-101.PRE 11714
7 EXTRACTED XBRL INSTANCE DOCUMENT d520938d8k_htm.xml XML 3595
Mailing Address 301 BINNEY STREET SUITE 402 CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET SUITE 402 CAMBRIDGE MA 02142 617-401-9975
SYNLOGIC, INC. (Filer) CIK: 0001527599 (see all company filings)

IRS No.: 261824804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37566 | Film No.: 231017361
SIC: 2834 Pharmaceutical Preparations